Innovating Works

PFA

Desconocido
EPISTOP: Long term prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a ge... PROTEOME FACTORY AG participó en un FP7: Despite a great progress in the management of epilepsy, still one third of patients is refractory to available medications. The incidence of...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.